AC
Acura Pharmaceuticals, Inc.
ACUR · OTC
$0.00 +0.00% (+$0.00)
1M +1.00%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
Asset turnover N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Debt/Assets N/A
Stability
39 /100
Moderate Beta -3.59x
Rev. volatility 68.53%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ACUR
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Robert Jones
Employees
9
Headquarters
Palatine